Syok Clinical
-
Upload
sukhrian-muhda -
Category
Documents
-
view
222 -
download
0
Transcript of Syok Clinical
-
8/11/2019 Syok Clinical
1/37
Syokdan
Tatalaksana terapi cairanRahardjo.
s
-
8/11/2019 Syok Clinical
2/37
-
8/11/2019 Syok Clinical
3/37
Klasifikasi :
1. Shock Hypovolemik : Shock o.k : Penurunan volume intravaskuler, misal : perdarahan, dehidrasi
2. Shock Kardiogenik : Shock o.k : Kegagalan pompa jantung, abnormalitas katub ataukah arritmia
3. Shock Obstruktif : Shock o.k : Hambatan aliran darah yg kembali kejantung ( venous return ), misal :
Tamponade jantung, konstriktif perikarditis, tension pneumothoraks
4. Shock Distributif : Shock o.k : Gangguan vasomotor mengakibatkan turunnya SVR diikuti Curah Jantung yang
tidak adekwat misal : Septic, Spinal, Nerogenic shock.
-
8/11/2019 Syok Clinical
4/37
TandaTanda Shock
1. Takikardia
2. Akral dingin
3. Kesadaran
4. Takipnea
5. Tensi
shock !
-
8/11/2019 Syok Clinical
5/37
-
8/11/2019 Syok Clinical
6/37
KLASIFIKASISYOKHEMORAGIK
Kompensasi Ringan Sedang Berat
Hilangdarah(ml)
Denyutnadi
(bpm)
Tekanan darah
Pengisian kapiler
Pernafasan
Urine(ml/h)
Statusmental
100Ortostatik
Mungkin
terlambat
Peningkatan
ringan
2030
Agitasi
15002000
>120Sangatturun
Sering
terlambat
Takipnea
sedang
520
Konfusi
>2000
>140Tidakterukur
Selalu
terlambat
Takipneunyata,
GagalNafas
Anuria
Letargi,
tidaksadar
Diagnosis
-
8/11/2019 Syok Clinical
7/37
GAMBARAN
KLINIK
SYOK
HEMORHAGISISTIM SYOKDINI SYOKLANJUT
SARAFPUSAT PERUBAHAN
STATUS
MENTALPERUBAHAN
KESADARAN
KARDIAL TAKIKARDI
HIPOTENSIORTOSTATIK
HIPOTENSI
ARITHMIA
GAGAL JANTUNGRENAL OLIGOURI ANURI
RESPIRASI TAKIPNOE TAKIPNOE,GAGALNAFAS
HEPATIK GANGGUAN FUNGSI
HEPAR
GASTROINTESTINAL PERDARAHANMUKOSA
HEMATOLOGI ANEMIA KOAGULOPATI
METABOLIK
ASIDOSISHIPOKALEMIA
HIPOMAGNESEMIADiagnosis
-
8/11/2019 Syok Clinical
8/37Penanganan
TatalaksanaSyok:
Penanganan
Syok
:
Tatalaksana
terhadap
Underlying
injury
or
Disease
Mengembalikan
Perfusi
Jaringan.
Segera
memberi
/
mengganti
Volume
Adekuat
Ventilation
&
Oxygenation
Adekuat
-
8/11/2019 Syok Clinical
9/37Penanganan
Penangananterhadap Underlyinginjuryordisease
TatalaksanaSyok:
-
8/11/2019 Syok Clinical
10/37
ENHANCEMENTMICROCIRCULATIONBLOODFLOW
Arterioles
and
arterial
partofcapillaries
Venules
and
venouspart
of
capillaries
MengembalikanPerfusi
Jaringan
Penanganan
TatalaksanaSyok:
-
8/11/2019 Syok Clinical
11/37
-
8/11/2019 Syok Clinical
12/37
PENTING !l VOLUME INTRAVASKULAR
l O2TRANSPORT
(ERITROSIT
)
JUMLAHOKSIGENYANGTERSEDIAUNTUKJARINGAN:
DO2=COX(SAT.O2XHbX1.39+PO2X0.003)
= 5 l/m X 20 l/mO2/100ml
= 1literO2/m
KEBUTUHAN=25%=250mlO2/m
-
8/11/2019 Syok Clinical
13/37
OxygenDelivery=
COxCaO2(HbxSpO2x1,39+0,003xPaO2)
O2content,O2extractingRatio,O2Consumption
DeterminanuntukTissueoxygenation
Komponen:CardiacOutput,Hb,
SpO2arterial&venousblood
-
8/11/2019 Syok Clinical
14/37
AdequateVentilationandOxygenation
TatalaksanaSyok:
-
8/11/2019 Syok Clinical
15/37
End Point of Resuscitation Therapy :
BasicClinicalSign: PatientResponses
HR
>
BPEvaluasithdPerfusi:
UOP(UrineOutPut)
CRT(CirculationPeripheral),
LOC(Level
of
Consciousness
)
Produksi Urin/jam
Tidak adekwatnya UOPberarti
Tidak adekwatnya resusitasi
-
8/11/2019 Syok Clinical
16/37
Advancedmethodsinclude
Metabolik
Serumlactate
pCO2
Base
deficit Mixedvenoussaturations
CVP : Preload.
AdvancedEvaluation
:
CO,CI,LAP,PAOP,LVSVWI
End Point of Resuscitation Therapy :
-
8/11/2019 Syok Clinical
17/37
KontroversialPoin
PeningkatanBPmeningkatkanresikoperdarahanpadakasus
perdarahan.
PemberianCairandanDarahakanmenurunkancoagulosi
MacamCairan:
Fluidvs.
non
fluid
(vasopressors,
etc.)
Bloodvs.nonbloodfluid
Wholebloodvs.bloodcomponents
Crystalloidsvs.
colloids
vs.
hypertonic
saline
Albuminvs.syntheticcolloids
-
8/11/2019 Syok Clinical
18/37
-
8/11/2019 Syok Clinical
19/37
KONSEPBARU
PERMISSIVEHYPOTENSION
Pasientetapsadar
Naditeraba
SBP90mmHg
MAP5060mmHg
SaO2>92%
-
8/11/2019 Syok Clinical
20/37
TERAPI
CAIRAN
PADA
SYOK
HEMORRHAGITujuanResusitasiCairan;
MenujuNormovolumi
dan
HD
stabil.
MemeliharaadekuatColloidOncoticPressure
Memeliharakeseimbangan
dan
komposisi
KompartemenCairanTubuh.
-
8/11/2019 Syok Clinical
21/37
RL
RANaCl0.9%
NaCl3%
Albumin
PlasmaDextran
Gelatin
HES
COLLOIDCRYSTALLOID
B
L
O
O
D
-
8/11/2019 Syok Clinical
22/37
Body Fluid CompartmentsTotal body water = 60 % of body weight (BW)
2/3
Intracellular water= 40 % of BW
1/3
Extracellularwater
= 20 % of BW
Plasma (5 % of BW)
Extracellularwater
= 20 % of BW
-
8/11/2019 Syok Clinical
23/37
increases ICF > ECFincreases ICF > ECF
ICF ISF PlasmaICF ISF Plasma
Replace Normalloss (IWL + urine)
Replace Normalloss (IWL + urine)
Hypotonic infusionHypotonic infusion 5% dextrose 5% dextrose
85 ml85 ml255 ml255 ml660 ml660 ml
-
8/11/2019 Syok Clinical
24/37
increases ECFincreases ECF
ICF ISF PlasmaICF ISF Plasma
Replace acute/abnormalloss
Replace acute/abnormalloss
Infus IsotonicInfus Isotonic
800 ml 200 ml
Ringers acetate
Ringers lactate Normal saline
Ringers acetate
Ringers lactate Normal saline
-
8/11/2019 Syok Clinical
25/37
KRISTALOID
Keuntungan
Komposisi elektrolit seimbang
Tidak ada resiko alergi
Tidak mempengaruhi hemostasis
Mengakibatkan terjadinya diuresis Murah
-
8/11/2019 Syok Clinical
26/37
Kerugian
Perlu 3-4 x jumlah perdarahan
Bisa mengakibatkan udem Mengakibatkan TOP berkurang.
Hypothermia
Lama kerja + 90 menit
NaCl 0.9% : asidosis hiperchloremia
KRISTALOID
-
8/11/2019 Syok Clinical
27/37
0
50
100
150
200
250
D5WLactatedRingers
Albumin5 %
Volume(ml)
Prough, Anesthesiology Clinics of North America (1996)
Administration of 250 ml of fluid
ICV
ISV
PV
-
8/11/2019 Syok Clinical
28/37
-
8/11/2019 Syok Clinical
29/37
-
8/11/2019 Syok Clinical
30/37
KOLOID
KEUNTUNGAN
Tetapberada
dalam
volume
intravaskular
Kebutuhansamadenganjumlahdarahyang
hilang
MeningkatkanTOP
Resikoudemminimal
Meningkatkanaliran
darah
microvaskular
-
8/11/2019 Syok Clinical
31/37
KERUGIAN
Kelebihan beban cairan
Mengganggu hemostasis
Mempengaruhi fungsi ginjal
Reaksi anafilaktoid
Mahal
KOLOID
-
8/11/2019 Syok Clinical
32/37
16 hr
16 hr
17 day
10 hr
6 hr
12 hr
0.7 1.3
4.0 5.0
1.0 1.3
1.5
1.0 1.5
0.8
20 mm Hg
70 Mm Hg
30 Mm Hg
40 Mm Hg
40 Mm Hg
40 Mm Hg
69.000
69.000
69.000
120.000
26.000
41.000
5 % ALBUMIN
25 % ALBUMIN
6 % HETASTARCH
10 % PENTASTARCH
10 % DEXTRAN-40
6 % DEXTRAN-70
SERUM
HALF-LIFE
PLASMA
VOLUME
EXPANSION***
ONCOTIC
PRESSURE**
AVERAGE
MOLECULAR
WEIGHT * (DALTONS)FLUID
CHARACTERISTICS OF INTRAVENOUS
COLLOID FLUIDS
-
8/11/2019 Syok Clinical
33/37
-
8/11/2019 Syok Clinical
34/37
http://content.nejm.org/http://content.nejm.org/content/vol345/issue19/images/large/03f2.jpeg -
8/11/2019 Syok Clinical
35/37
Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock
CVP
denotes
central
venous
pressure,
MAP
mean
arterial
pressure,
and
ScvO2centralvenousoxygensaturation
Volume 345:1368-1377 November 8, 2001 Number 19
http://content.nejm.org/http://content.nejm.org/content/vol345/issue19/images/large/03f2.jpeg -
8/11/2019 Syok Clinical
36/37
TREATMENT CONCEPT OF SHOCK
ENHANCING PERFUSION / OXYGEN DELIVERY
Oxygen delivery/DO2 = HR X SV X HbXSp02X1.39 + 0.03 X PaO2
Cardiacoutput
Arterial O2content
FluidsTransfuse Partially
dependent onFIO2 and
pulmonary
status
Inotropes :Dopamin
Dobutamin
Norepinephrin
Epinephrin
DO2 = CO x CaO2
ScvO2
-
8/11/2019 Syok Clinical
37/37